Sandeep C. Kulkarni's most recent trade in Zura Bio Ltd - Ordinary Shares - Class A was a trade of 894,000 Employee Share Option (Right to Buy) done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zura Bio Ltd (Class A) | Sandeep C. Kulkarni | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 894,000 | 894,000 | - | - | Employee Share Option (Right to Buy) | |
| Zura Bio Ltd (Class A) | Sandeep C. Kulkarni | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 2,934,107 | 2,934,107 | - | - | Employee Share Option (Right to Buy) | |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | 28 Oct 2025 | 724,664 | 30,387 | - | - | Common Stock | ||
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Oct 2025 | 503,478 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Oct 2025 | 254,207 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Oct 2025 | 226,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Oct 2025 | 30,387 | 0 | - | - | Common Stock | |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | 28 Oct 2025 | 7,000 | 0 | - | - | Common Stock | ||
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 25,316 | 503,478 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.90 per share. | 22 Oct 2025 | 25,316 | 755,051 | - | 7.9 | 199,996 | Common Stock |
| Zura Bio Ltd (Class A) | Sandeep C. Kulkarni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 51,000 | 51,000 | - | - | Share Option (Right to Buy) | |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 226,000 | 226,000 | - | - | Employee Stock Option (Right to Buy) | |
| Zura Bio Ltd (Class A) | Sandeep C. Kulkarni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 117,000 | 117,000 | - | - | Share Option (Right to Buy) | |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Purchase of securities on an exchange or from another person at price $ 14.85 per share. | 21 Aug 2024 | 1,779 | 7,000 | - | 14.8 | 26,418 | Common Stock |
| Tourmaline Bio Inc | Sandeep C. Kulkarni | Director, CEO | Purchase of securities on an exchange or from another person at price $ 13.79 per share. | 16 Aug 2024 | 5,221 | 5,221 | - | 13.8 | 71,998 | Common Stock |
| Zura Bio Ltd (Class A) | Sandeep C. Kulkarni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 207,520 | 207,520 | - | - | Employee Share Option (Right to Buy) |